Skip to main content

Table 3 Association between perioperative scopolamine administration and postoperative delirium

From: A comprehensive analysis of in-hospital adverse events after scopolamine administration: insights from a retrospective cohort study using a large nationwide inpatient database

Cohort

Patients in Cohort (after matching)

Patients with delirium

Risk (%)

Relative Risk

Confidence Interval (95%)

P value

Surgery & Scopolamine 70+

59,050

811

1.373%

1.291

(1.164 to 1.432)

< 0.0001

Surgery & No Scopolamine 70+

59,050

628

1.064%

   

Surgery & Scopolamine 60–69

44,193

316

0.715%

1.45

(1.22 to 1.722)

< 0.0001

Surgery & No Scopolamine 60–69

44,193

218

0.493%

   

Surgery & Scopolamine 50–59

35,830

155

0.433%

1.23

(0.973 to 1.555)

0.0830

Surgery & No Scopolamine 50–59

35,830

126

0.352%

   

Surgery & Scopolamine 40–49

29,295

90

0.307%

1.098

(0.814 to 1.48)

0.5413

Surgery & No Scopolamine 40–49

29,295

82

0.28%

   

Surgery & Scopolamine 30–39

22,085

70

0.317%

0.909

(0.658 to 1.256)

0.5631

Surgery & No Scopolamine 30–39

22,085

77

0.349%

   

Surgery & Scopolamine 20–29

11,455

35

0.306%

1.129

(0.697 to 1.83)

0.6220

Surgery & No Scopolamine 20–29

11,455

31

0.271%

  Â